Published by Coherent Market Insights
Posted on September 16, 2021
6 min readLast updated: January 20, 2026
Risk-based monitoring is a monitoring technique, which is important to ensure patient safety, and also to maintain high quality of data. It provides the clinical team with a single platform that transforms multiple study data streams into flexible analytics. Risk-based monitoring employs various platforms and tools to identify potential issues related to trial conduct, compliance, data integration, and security. This helps reduce costs associated with clinical studies. The event/condition is monitored by measuring it against a standard set of parameters.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/3575
Market Dynamics:
Increasing number of clinical trials and the emergence of COVID-19 is expected to propel the growth of the risk-based monitoring market. For instance, according to the Ministry of Science and Technology (China), China is conducting clinical trials of 16 COVID-19 vaccines, of which seven have entered phase-III trials and one has conditionally hit the market. Moreover, according to NITI Aayog (India), six COVID-19 vaccines are currently undergoing clinical trials in the country.
Moreover, cost and time efficiency of risk-based monitoring solutions and the increasing government funding to support clinical trials is expected to augment the growth of the risk-based monitoring software market. For instance, in October 2020, the United States Food and Drug Administration (USFDA) awarded six new clinical trial research grants to principal investigators from academia and industry totaling over US$ 16 million over the next four years.
Increasing outsourcing of clinical trials to contract research organizations (CROs) is expected to offer lucrative growth opportunities for players in the risk-based monitoring market. For instance, in March 2021, Innoforce and dMed, a clinical CRO, teamed up to identify, assess, and collaborate on the development of clinical-stage therapeutics. However, the high cost of implementation is expected to restrain growth of the market.
Risk-Based Monitoring Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of TransCelerate, Bio Pharma Inc., Covance solution, Quanticate Ltd, IQVIA, Parexel, JMP clinical, and Cintec.
Major players in the market are adopting various business strategies, such as partnership and collaboration, to strengthen their market presence. For instance, in November 2019, Veeva Systems completed its acquisition of Crossix Solutions to help maximize media and marketing effectiveness.
In September 2018, PAREXEL International Corporation and Datavant, Inc., partnered to deliver advanced data and real-world evidence analytics to improve drug development and commercialization processes.
In May 2018, Bioclinica launched its expanded and enhanced SMART technology suite available with Interactive Response Technology (IRT), Electronic Data Capture (EDC), and Medical Imaging combined.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/3575
Reasons to Purchase this Report
• Current and future of global Risk-Based Monitoring Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Risk-Based Monitoring Market Therapeutics, Rising Industry Size, Growth Opportunity, Latest Technology and Development Analysis By Top Key Players appeared first on Gatorledger.
Risk-based monitoring is a monitoring technique, which is important to ensure patient safety, and also to maintain high quality of data. It provides the clinical team with a single platform that transforms multiple study data streams into flexible analytics. Risk-based monitoring employs various platforms and tools to identify potential issues related to trial conduct, compliance, data integration, and security. This helps reduce costs associated with clinical studies. The event/condition is monitored by measuring it against a standard set of parameters.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/3575
Market Dynamics:
Increasing number of clinical trials and the emergence of COVID-19 is expected to propel the growth of the risk-based monitoring market. For instance, according to the Ministry of Science and Technology (China), China is conducting clinical trials of 16 COVID-19 vaccines, of which seven have entered phase-III trials and one has conditionally hit the market. Moreover, according to NITI Aayog (India), six COVID-19 vaccines are currently undergoing clinical trials in the country.
Moreover, cost and time efficiency of risk-based monitoring solutions and the increasing government funding to support clinical trials is expected to augment the growth of the risk-based monitoring software market. For instance, in October 2020, the United States Food and Drug Administration (USFDA) awarded six new clinical trial research grants to principal investigators from academia and industry totaling over US$ 16 million over the next four years.
Increasing outsourcing of clinical trials to contract research organizations (CROs) is expected to offer lucrative growth opportunities for players in the risk-based monitoring market. For instance, in March 2021, Innoforce and dMed, a clinical CRO, teamed up to identify, assess, and collaborate on the development of clinical-stage therapeutics. However, the high cost of implementation is expected to restrain growth of the market.
Risk-Based Monitoring Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of TransCelerate, Bio Pharma Inc., Covance solution, Quanticate Ltd, IQVIA, Parexel, JMP clinical, and Cintec.
Major players in the market are adopting various business strategies, such as partnership and collaboration, to strengthen their market presence. For instance, in November 2019, Veeva Systems completed its acquisition of Crossix Solutions to help maximize media and marketing effectiveness.
In September 2018, PAREXEL International Corporation and Datavant, Inc., partnered to deliver advanced data and real-world evidence analytics to improve drug development and commercialization processes.
In May 2018, Bioclinica launched its expanded and enhanced SMART technology suite available with Interactive Response Technology (IRT), Electronic Data Capture (EDC), and Medical Imaging combined.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/3575
Reasons to Purchase this Report
• Current and future of global Risk-Based Monitoring Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Risk-Based Monitoring Market Therapeutics, Rising Industry Size, Growth Opportunity, Latest Technology and Development Analysis By Top Key Players appeared first on Gatorledger.
Explore more articles in the Research Reports category
